Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2026-05-13 @ 10:27 AM
Study NCT ID:
NCT00921167
Status:
COMPLETED
Last Update Posted:
2013-12-04
First Post:
2009-06-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas
Sponsor:
Clinical Research Center for Solid Tumor, Korea
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CRCST-L-0006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |